PHARMAPRODUCTS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAPRODUCTS
Largest movements
- Cash +€112,550
up €112,550 (+418.2%), from €26,913 to €139,462
mainly Debts after one year (+€120,850) and Trade debts (+€100,581)
- Stocks and contracts +€61,043
up €61,043 (+61.1%), from €99,948 to €160,990
- Receivables within one year +€15,971
up €15,971 (+14.4%), from €110,608 to €126,579
of which Trade receivables: +€22,392
- Deferred charges and accrued income -€11,029
down €11,029 (-96.5%), from €11,429 to €400
- Other debts -€139,299
down €139,299 (-100.0%), from €139,358 to €59
- Debts after one year +€120,850
new in 2025: €120,850
- Trade debts +€100,581
up €100,581 (+198.4%), from €50,709 to €151,290
- Reserves +€69,113
up €69,113 (+110.4%), from €62,587 to €131,700
of which Distributable reserves: +€69,113
- Tax, wage and social debts +€16,281
up €16,281 (+249.5%), from €6,524 to €22,805
of which Taxes: +€10,144
- Gross operating margin -€38,301
down €38,301 (-17.7%), from €216,304 to €178,003
- Taxes +€23,644
up €23,644 (+2761.3%), from €856 to €24,500
- Financial charges +€5,748
up €5,748 (+270.6%), from €2,124 to €7,872
- Staff costs -€4,016
down €4,016 (-6.0%), from €67,358 to €63,341
- Financial income +€2,824
up €2,824 (+340.2%), from €830 to €3,653
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €321,179 | €501,031 | +€179,852 | +56.0% |
| Fixed assets | 21/28 | €72,281 | €73,599 | +€1,318 | +1.8% |
| Tangible fixed assets | 22/27 | €72,281 | €73,599 | +€1,318 | +1.8% |
| Land and buildings | 22 | €52,913 | €61,062 | +€8,148 | +15.4% |
| Plant, machinery and equipment | 23 | €9,231 | €6,515 | -€2,716 | -29.4% |
| Furniture and vehicles | 24 | €10,137 | €6,023 | -€4,114 | -40.6% |
| Current assets | 29/58 | €248,898 | €427,431 | +€178,534 | +71.7% |
| Stocks and contracts in progress | 3 | €99,948 | €160,990 | +€61,043 | +61.1% |
| Stocks | 30/36 | €99,948 | €160,990 | +€61,043 | +61.1% |
| Amounts receivable within one year | 40/41 | €110,608 | €126,579 | +€15,971 | +14.4% |
| Trade receivables | 40 | €102,691 | €125,084 | +€22,392 | +21.8% |
| Other amounts receivable | 41 | €7,916 | €1,495 | -€6,422 | -81.1% |
| Cash at bank and in hand | 54/58 | €26,913 | €139,462 | +€112,550 | +418.2% |
| Deferred charges and accrued income | 490/1 | €11,429 | €400 | -€11,029 | -96.5% |
| Total equity and liabilities | 10/49 | €321,179 | €501,031 | +€179,852 | +56.0% |
| Equity | 10/15 | €124,587 | €193,827 | +€69,239 | +55.6% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €62,587 | €131,700 | +€69,113 | +110.4% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €56,387 | €125,500 | +€69,113 | +122.6% |
| Profit (loss) carried forward | 14 | €0 | €127 | +€127 | |
| Amounts payable | 17/49 | €196,591 | €307,204 | +€110,613 | +56.3% |
| Amounts payable after more than one year | 17 | - | €120,850 | +€120,850 | |
| Financial debts | 170/4 | - | €120,850 | +€120,850 | |
| Amounts payable within one year | 42/48 | €196,591 | €186,354 | -€10,237 | -5.2% |
| Current portion of amounts payable after more than one year | 42 | - | €12,200 | +€12,200 | |
| Trade debts | 44 | €50,709 | €151,290 | +€100,581 | +198.4% |
| Suppliers | 440/4 | €50,709 | €151,290 | +€100,581 | +198.4% |
| Taxes, remuneration and social security | 45 | €6,524 | €22,805 | +€16,281 | +249.5% |
| Taxes | 450/3 | €356 | €10,500 | +€10,144 | +2847.5% |
| Remuneration and social security | 454/9 | €6,168 | €12,305 | +€6,137 | +99.5% |
| Other amounts payable | 47/48 | €139,358 | €59 | -€139,299 | -100.0% |
| Remuneration, social security and pensions | 62 | €67,358 | €63,341 | -€4,016 | -6.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,197 | €13,922 | +€1,726 | +14.2% |
| Other operating charges | 640/8 | €2,822 | €2,781 | -€41 | -1.5% |
| Gross operating margin | 9900 | €216,304 | €178,003 | -€38,301 | -17.7% |
| Operating profit (loss) | 9901 | €133,927 | €97,958 | -€35,969 | -26.9% |
| Financial income | 75/76B | €830 | €3,653 | +€2,824 | +340.2% |
| Recurring financial income | 75 | €830 | €3,653 | +€2,824 | +340.2% |
| Financial charges | 65/66B | €2,124 | €7,872 | +€5,748 | +270.6% |
| Recurring financial charges | 65 | €2,124 | €7,872 | +€5,748 | +270.6% |
| Profit (loss) for the period before taxes | 9903 | €132,633 | €93,739 | -€38,894 | -29.3% |
| Income taxes | 67/77 | €856 | €24,500 | +€23,644 | +2761.3% |
| Profit (loss) for the period | 9904 | €131,777 | €69,239 | -€62,538 | -47.5% |
| Profit (loss) for the period to be appropriated | 9905 | €131,777 | €69,239 | -€62,538 | -47.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.